Specialty distributor BioCareSD has added Uplinza to its specialty therapeutics portfolio to service a wider patient population and broaden the company’s diverse product offering.
Uplizna is used to treat adults with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 (AQP4) antibody positive. The medication is available through BioCareSD’s dependable specialty distribution network.
[Read more: BioCareSD provides 2 new specialty medications]
“We are continuously anticipating, identifying and supporting the unmet needs of our customers,” said Andrew Kirk, chief operating officer at BioCareSD. “And we are committed to broadening our portfolio of product offerings as new life-saving medications become available, further increasing access to critical therapeutics that serve more patient groups.”
[Read more: Retailers build out their specialty offerings]